- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Immune-related Adverse Events in Australia
Total 330 results
-
Janssen Research & Development, LLCMayo ClinicRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia, Israel
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Russian Federation, United States, Australia, Greece, Argentina, Hungary, Brazil, Mexico, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico, Russian Federation, United Kingdom, Denmark, France, Israel, Australia, Romania
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
Medical University InnsbruckRecruitingRecurrent Ovarian CarcinomaAustria
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
Eli Lilly and CompanyTerminatedDiabetic Nephropathy | Diabetic Kidney Disease | Diabetic GlomerulosclerosisIsrael, Hungary, United States, Australia, France, Czechia, Puerto Rico
-
Hoffmann-La RocheRecruitingThyroid Eye Disease | TEDJapan, Australia, Singapore, United States, Argentina, Germany, Italy, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery SystemsItaly, United Kingdom, Austria, Netherlands, Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1India, Macedonia, The Former Yugoslav Republic of, Malaysia, Turkey, Croatia, Bulgaria, Romania, Australia, South Africa, Argentina
-
Medtronic DiabetesCompletedDiabetes Mellitus, Type 1Denmark, Spain, Belgium, Serbia, Sweden, Austria, France, Hungary, Israel, Italy, Lithuania, Poland, Slovakia, Slovenia
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
Abbott Diabetes CareCompletedType 1 Diabetes MellitusAustria, Netherlands, Germany, Spain, Sweden
-
Novartis PharmaceuticalsCompletedCancerFrance, Spain, Netherlands, Canada, Austria, United States, Germany, Italy, Japan, Norway, Korea, Republic of, Denmark, Sweden, Belgium
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Austria, Switzerland, United Kingdom, Germany, Ireland
-
EUROSPK Study GroupWyeth is now a wholly owned subsidiary of Pfizer; Hoffmann-La Roche; Genzyme,... and other collaboratorsCompletedDiabetes Mellitus, Type 1 | Diabetic NephropathyBelgium, Israel, Germany, Austria, Czechia, Spain, Switzerland
-
Andromeda Biotech Ltd.CompletedType 1 DiabetesFrance, Italy, United Kingdom, Israel, South Africa, Spain, Austria, Czech Republic, Finland, Germany, Greece
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, Austria, South Africa
-
University of CambridgeJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsUnknownType 1 Diabetes MellitusAustria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
-
AGO Study GroupArbeitsgemeinschaft Gynaekologische Onkologie Austria; MITOCompletedOvarian CancerGermany, Belgium, Italy, Austria
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada, United Kingdom, Australia
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | AsthmaUnited States, Slovakia, India, Malaysia, Australia, Former Serbia and Montenegro
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
Therapeutic Advances in Childhood Leukemia ConsortiumGlaxoSmithKline; NovartisTerminatedRelapsed T-Cell Acute Lymphoblastic Leukemia | Relapsed T-Cell Lymphoblastic LymphomaUnited States, France, Canada, Australia, Austria, Italy, Netherlands
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, United Kingdom, Canada, Italy, Hungary, Spain, Sweden, Australia, Netherlands, France, Czechia, Finland, Germany, Greece, Ireland, Latvia, Mexico, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, South...
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Poland, United Kingdom, France, Sweden, Netherlands, Finland, Belgium, Ireland, Germany, Canada, Russian Federation, Australia, Norway, Argentina, Ukraine
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Germany, Austria, Denmark, Norway, Sweden, Switzerland, Finland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Ovarian Cancer | Brain Tumor | Ototoxicity | Neuroblastoma | Liver Cancer | Central Nervous System Tumor | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorCanada, United States, Australia
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania, Slovakia, Israel, Saudi Arabia, India, Malaysia, Mexico, Russian Federation, Germany, Croatia, Poland, Serbia, Bulgaria, Canada, Slovenia, Sweden, Denmark, Hungary, Argentina, Austria, Finland, Lebanon, Czechia, Netherlands
-
AmgenTerminatedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Italy, Belgium, Canada, Mexico, Germany, Korea, Republic of, United Kingdom, Taiwan, Australia, Spain, Austria, Israel, Czechia, Greece, Russian Federation, Poland, Turkey, Bulgaria, Ireland
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Gynecologic Oncology GroupBristol-Myers Squibb; National Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Norway, Canada, Australia, Japan
-
PfizerTerminatedDiabetes Mellitus, Type 1Denmark, Spain, Sweden, United States, Belgium, Austria, France, Portugal, Ireland, United Kingdom, Finland, Netherlands, Norway
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Denmark, Canada, France, Netherlands, Austria, Israel, Finland, Russian Federation, Croatia, Bulgaria, Poland, Ireland, Spain, Norway, Greece, Argentina, Germany
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Austria, Germany, Italy, Spain, United Kingdom, Belgium, Mexico, Israel, Hungary, Canada, Australia, Denmark, Sweden, Romania, France, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States, India, Italy, Russian Federation, United Kingdom, Canada, Netherlands, Austria, Japan, Spain, Germany, Turkey
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
Viracta Therapeutics, Inc.RecruitingEBV Related Non-Hodgkin's Lymphoma | Epstein-Barr Virus Associated Lymphoproliferative Disorder | EBV-Related PTLD | EBV Associated Lymphoma | EBV-Positive DLBCL, NOS | EBV Related PTCL, NOSUnited States, Spain, Italy, United Kingdom, Singapore, Taiwan, Korea, Republic of, Germany, Canada, Brazil, Australia, France, Malaysia, Hong Kong, Israel